JP2024526882A5 - - Google Patents

Info

Publication number
JP2024526882A5
JP2024526882A5 JP2024503546A JP2024503546A JP2024526882A5 JP 2024526882 A5 JP2024526882 A5 JP 2024526882A5 JP 2024503546 A JP2024503546 A JP 2024503546A JP 2024503546 A JP2024503546 A JP 2024503546A JP 2024526882 A5 JP2024526882 A5 JP 2024526882A5
Authority
JP
Japan
Prior art keywords
compound
solvate
hcl
cocrystal
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024526882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/037928 external-priority patent/WO2023004075A1/en
Publication of JP2024526882A publication Critical patent/JP2024526882A/ja
Publication of JP2024526882A5 publication Critical patent/JP2024526882A5/ja
Pending legal-status Critical Current

Links

JP2024503546A 2021-07-21 2022-07-21 Kif18a阻害剤化合物の塩及び固体状形態 Pending JP2024526882A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163224208P 2021-07-21 2021-07-21
US63/224,208 2021-07-21
PCT/US2022/037928 WO2023004075A1 (en) 2021-07-21 2022-07-21 Salts and solid state forms of a kif18a inhibitor compound

Publications (2)

Publication Number Publication Date
JP2024526882A JP2024526882A (ja) 2024-07-19
JP2024526882A5 true JP2024526882A5 (https=) 2025-07-29

Family

ID=83148993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503546A Pending JP2024526882A (ja) 2021-07-21 2022-07-21 Kif18a阻害剤化合物の塩及び固体状形態

Country Status (13)

Country Link
US (1) US20240327384A1 (https=)
EP (1) EP4373818A1 (https=)
JP (1) JP2024526882A (https=)
KR (1) KR20240051338A (https=)
CN (1) CN117940416A (https=)
AR (1) AR126537A1 (https=)
AU (1) AU2022313961A1 (https=)
CA (1) CA3226614A1 (https=)
IL (1) IL310234A (https=)
MX (1) MX2024000990A (https=)
TW (1) TW202321213A (https=)
UY (1) UY39866A (https=)
WO (1) WO2023004075A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA54543A (fr) 2018-12-20 2022-03-30 Amgen Inc Inhibiteurs de kif18a
IL310863A (en) 2021-08-26 2024-04-01 Volastra Therapeutics Inc Spiro indoline inhibitors of kif18a
EP4509505A4 (en) * 2022-04-15 2026-04-15 Wuhan Humanwell Innovative Drug Res And Development Center Limited Company KIF18A INHIBITOR AND ITS USAGE
TW202416973A (zh) 2022-08-18 2024-05-01 美商雅客森醫療公司 Kif18a抑制劑及其用途
CN116535400B (zh) * 2023-04-26 2024-08-16 上海湃隆生物科技有限公司 氮杂螺环化合物及其应用
WO2025077882A1 (zh) * 2023-10-13 2025-04-17 武汉人福创新药物研发中心有限公司 Kif18a抑制剂化合物的盐、晶型及其制备方法和用途
WO2025185704A1 (zh) * 2024-03-07 2025-09-12 长春金赛药业有限责任公司 一种kif18a抑制剂的晶型及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8576985B2 (en) 2009-09-01 2013-11-05 Aptuit (West Lafayette) Llc Methods for indexing solid forms of compounds
MA54543A (fr) 2018-12-20 2022-03-30 Amgen Inc Inhibiteurs de kif18a
MX2022012992A (es) * 2020-04-14 2022-11-08 Amgen Inc Inhibidores de kif18a para el tratamiento de enfermedades neoplasicas.

Similar Documents

Publication Publication Date Title
JP2024526882A5 (https=)
CN114846006A (zh) 杂环化合物及其制备方法和用途
JP5916752B2 (ja) 5−クロロ−n2−(2−イソプロポキシ−5−メチル−4−ピペリジン−4−イル−フェニル)−n4[2−(プロパン−2−スルホニル)−フェニル]−ピリミジン−2,4−ジアミンの結晶形
US9630952B2 (en) Crystalline forms of afatinib di-maleate
US8518936B2 (en) Method for preparing acid addition salts of polyacidic basic compounds
PT1912973E (pt) Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5 trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
US10800763B2 (en) Polymorphic forms of Afatinib free base and Afatinib dimaleate
US10550101B2 (en) Crystalline forms of mesylate salt of pyridinyl amino pyrimidine derivative, preparation methods therefor, and applications thereof
WO2017152706A1 (zh) 吡啶胺基嘧啶衍生物的盐及其制备方法和应用
EP3430004B1 (en) Solid state forms of nilotinib salts
JP5378499B2 (ja) 微小管形成阻害剤として有用なベンゾフェノンチアゾール誘導体及びその製造方法
EP3271351A1 (en) Novel polymorphic form x of nilotinib dihydrochloride hydrate
US20200308141A1 (en) Solid state forms of neratinib and salts thereof
JP2022531571A (ja) ジアミノピリミジン化合物の塩、及びその固体形態、その調製方法及びその使用
JP2022530889A (ja) ジアミノピリミジン化合物又はその水和物の固体形態、その調製方法及びその適用
JP5856971B2 (ja) 結晶性cdc7阻害剤塩
US10259805B2 (en) Process for making crystalline form a of gefitinib
US6872725B2 (en) Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole
CN119968370A (zh) 用于制备1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-n-甲基氮杂环丁烷-3-胺的盐和结晶形式的方法和新结晶形式
HK40072166A (en) Heterocyclic compounds, preparation methods and uses thereof
JP2004075563A (ja) 放射線増感剤
WO2017035170A1 (en) Solid state forms of cediranib maleate